Response to Hyperfractionated Accelerated Radiotherapy in Chemotherapy-Refractory Non-Hodgkin’s Lymphoma

$Response to Hyperfractionated Accelerated Radiotherapy in Chemotherapy-Refractory Non-Hodgkin’s Lymphoma$

Journal article

H Lee, B.A Mahal, M Lam, A.K Ng and D.W Kim

International journal of radiation oncology, biology, physics, Vol.105(1), pp.E471-E471

2019-09-01

Metrics

6 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Response to Hyperfractionated Accelerated Radiotherapy in Chemotherapy-Refractory Non-Hodgkin’s Lymphoma
Creators: H Lee - Massachusetts General Hospital, Boston, MA
B.A Mahal - Harvard Radiation Oncology Program, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, MA
M Lam - Department of Radiation Oncology, Brigham and Women's Hospital, Boston, MA
A.K Ng - Dana Farber Cancer Center, Boston, MA
D.W Kim
Publication Details: International journal of radiation oncology, biology, physics, Vol.105(1), pp.E471-E471
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Radiation Oncology
Language: English
Resource Type: Journal article
Record Identifier: 991031600183002976